|
Miltenyi Biotec
antibody human monoclonal anti mouse dectin1apc miltenyi Antibody Human Monoclonal Anti Mouse Dectin1apc Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Dectin-1+Antibody%2C+anti-mouse%2C+REAfinity/10__7554_slash_elife__72923-275-70-76 Average 93 stars, based on 1 article reviews
antibody human monoclonal anti mouse dectin1apc miltenyi - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
R&D Systems
murine anti dectin 1 mab 259931 Murine Anti Dectin 1 Mab 259931, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Dectin-1%2FCLEC7A+Antibody+(259931)+%5BmFluor+Violet+450+SE%5D/pmc03072717-118-9-13 Average 93 stars, based on 1 article reviews
murine anti dectin 1 mab 259931 - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
R&D Systems
monoclonal antibody Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Mouse+Dectin-1%2FCLEC7A+Antibody/pmc03530475-234-12-17 Average 90 stars, based on 1 article reviews
monoclonal antibody - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Novus Biologicals
anti clec7a dectin1 Anti Clec7a Dectin1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Dectin-1%2FCLEC7A+Antibody+(Baylor+patent+anti-Dectin-1)+-+Humanized/pm37864797-266-10-11 Average 91 stars, based on 1 article reviews
anti clec7a dectin1 - by Bioz Stars,
2026-08
91/100 stars
|
Buy from Supplier |
|
R&D Systems
anti dectin 1 pe antibody Anti Dectin 1 Pe Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Human+Dectin-1%2FCLEC7A+PE-conjugated+Antibody/pmc05495798-37-11-13 Average 92 stars, based on 1 article reviews
anti dectin 1 pe antibody - by Bioz Stars,
2026-08
92/100 stars
|
Buy from Supplier |
|
Bio-Rad
biotinylated anti mouse dectin 1 ab Biotinylated Anti Mouse Dectin 1 Ab, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Rat+anti+Mouse+Dectin-1/pmc05834765-124-33-39 Average 93 stars, based on 1 article reviews
biotinylated anti mouse dectin 1 ab - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
R&D Systems
clec7a protein ![]() Clec7a Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Recombinant+Human+Dectin-1%2FCLEC7A+Protein%2C+CF/pm37741158-110-2-5 Average 93 stars, based on 1 article reviews
clec7a protein - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
R&D Systems
mannose receptor mr ![]() Mannose Receptor Mr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Recombinant+Mouse+Dectin-1%2FCLEC7A+Protein%2C+CF/pmc05843349-87-16-24 Average 90 stars, based on 1 article reviews
mannose receptor mr - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
R&D Systems
anti dectin 1 ![]() Anti Dectin 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Mouse+Dectin-1%2FCLEC7A+Antibody/pm25490199-78-37-43 Average 90 stars, based on 1 article reviews
anti dectin 1 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
rabbit anti human dectin 1 antibody ![]() Rabbit Anti Human Dectin 1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Dectin-1+Rabbit+mAb/pmc04539646-93-42-48 Average 93 stars, based on 1 article reviews
rabbit anti human dectin 1 antibody - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
Novus Biologicals
polyclonal dectin ![]() Polyclonal Dectin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Dectin-1%2FCLEC7A+Antibody/10__1007_slash_s10570___024___06238___4-160-17-19 Average 92 stars, based on 1 article reviews
polyclonal dectin - by Bioz Stars,
2026-08
92/100 stars
|
Buy from Supplier |
|
R&D Systems
anti-human dectin1 ![]() Anti Human Dectin1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dectin+1/Human+Dectin-1%2FCLEC7A+Antibody/10__1165_slash_rcmb__2011___0159oc-53-4-14 Average 94 stars, based on 1 article reviews
anti-human dectin1 - by Bioz Stars,
2026-08
94/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Article Title: Levo-tetrahydropalmatine ameliorates neuropathic pain by inhibiting the activation of the Clec7a-MAPK/NF-κB-NLRP3 inflammasome axis.
doi: 10.1016/j.phymed.2023.155075
Figure Lengend Snippet: Fig. 2. Clec7a-MAPK/NF-κB-NLRP3 Inflammasome Axis might be an effective target of L-THP against NP. (A) Heat maps of DEGs in the CCI group compared with the Sham group (Left) and CCI+l-THP group (Right) by RNA-seq technology (n = 4 rats/group). In clustering analysis, upregulated and downregulated genes are colored red and blue, respectively. (B) Volcano plots of DEGs in the CCI group compared with the Sham group (Left) and CCI+l-THP group (Right). Blue represents downregulated genes; red represents upregulated genes (|Fold change|>1.2, p < 0.05). (C) Venn plots show the total number of identified DEGs in the spinal cord of the Sham, CCI, and CCI+l-THP groups. The overlapped area represented 156 of 636 altered genes in CCI, which were increased by L-THP treatment (Left). The overlapped area represented 24 of 613 altered genes in CCI, which were attenuated by L-THP treatment (Right). (D) qRT-PCR validation profiles of six randomly selected genes. The fold change values of relative expression patterns of different genes are shown on the left Y axis for qRT-PCR, and the FPKM of DEGs were shown on the right Y axis for RNA-seq. (E) The top 20 biological process(BP) terms in the enrichment analysis. (F) 23 enrichment KEGG signaling pathways. (G) Venn diagrams were severally generated by intersecting the DEGs in 3 biological process terms or 4 KEGG pathways related to inflammatory responses.
Article Snippet: First, the
Techniques: RNA Sequencing, Quantitative RT-PCR, Biomarker Discovery, Expressing, Protein-Protein interactions, Generated
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Article Title: Levo-tetrahydropalmatine ameliorates neuropathic pain by inhibiting the activation of the Clec7a-MAPK/NF-κB-NLRP3 inflammasome axis.
doi: 10.1016/j.phymed.2023.155075
Figure Lengend Snippet: Fig. 3. Intragastric administration of L-THP significantly attenuated CCI-induced neuropathic pain by regulating Clec7a-MAPK/NF-κB-NLRP3 inflammasome-induced pyroptosis axis. Pregabalin was used as a positive control drug. (A) Timeline schematic of the experimental paradigm. (B) Repetitive administration of L-THP at 32 and 64 mg/kg at postoperative 6–10 days significantly ameliorated the mechanical withdrawal threshold in the CCI rat model (n = 12 rats/group). (C) qRT-PCR analysis shows the mRNA levels of Clec7a and NLRP3 in the ipsilateral spinal cord of CCI rats on postoperative 10 days(n = 3 rats/group with 3 technical replicates). (D) Protein expressions of Clec7a, p-Syk/Syk, p-NF-κB-p65/NF-κB-p65, p-ERK/ERK, p-JNK/JNK, p-p38/p38 MAPK, NLRP3, GSDMD-N and Caspase-1 in the ipsilateral spinal cord of CCI rats on postoperative 10 days were measured using western blot analysis (n = 3 rats/group with 3 technical replicates). Data are presented as mean ± SEM. Two-way repeated measures ANOVA and Tukey’s post hoc test were used to analyze data at different time points (B). One-way ANOVA was used to analyze data among multiple groups, followed by Tukey’s post hoc test for equal variances or Dunnett’s T3 post hoc test for unequal variances (C-D). **p < 0.01, ***p < 0.001 compared with the Sham group; #p < 0.05, ##p < 0.01, ###p < 0.001 compared with the CCI group; △p < 0.05, △△p < 0.01, △△△p < 0.001 compared with the CCI+l-THP+l group.
Article Snippet: First, the
Techniques: Positive Control, Quantitative RT-PCR, Western Blot
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Article Title: Levo-tetrahydropalmatine ameliorates neuropathic pain by inhibiting the activation of the Clec7a-MAPK/NF-κB-NLRP3 inflammasome axis.
doi: 10.1016/j.phymed.2023.155075
Figure Lengend Snippet: Fig. 5. The overexpression of Clec7a partially inhibits the analgesic effect of L-THP. (A) Timeline schematic of the experimental paradigm. (B) Repetitive administration of L-THP at 64 mg/kg significantly ameliorated the mechanical withdrawal threshold (MWT) in the CCI rat model, while overexpression Clec7a reversed the MWT of CCI rats treated with L-THP (n = 4–10 rats/group). (C) Protein expressions of Clec7a, p-Syk/Syk, p-NF-κB-p65/NF-κB-p65, p-ERK/ERK, p-JNK/ JNK, p-p38/p38 MAPK, NLRP3, GSDMD-N and Caspase-1 in the ipsilateral spinal cord of CCI rats on postoperative 10 days were measured using western blot analysis (n = 3 rats/group with 3 technical replicates). (D) The concentrations of IL-1β and IL-18 in the serum of indicated groups were assessed by ELISA. Data are presented as mean ± SEM. Two-way repeated measures ANOVA and Tukey’s post hoc test were used to analyze data at different time points. One-way ANOVA was used to analyze data among multiple groups, followed by Tukey’s post hoc test for equal variances or Dunnett’s T3 post hoc test for unequal variances (C-D). **p < 0.01, ***p < 0.001 compared with the Sham group; △p < 0.05, △△p < 0.01, △△△p < 0.001 compared with the CCI group; #p < 0.05, ##p < 0.01, ###p < 0.001 compared with the CCI+pLVSO5–NC group; §p < 0.05, §§p < 0.01, §§§p < 0.001 compared with the CCI+pLVSO5–Clec7a group.
Article Snippet: First, the
Techniques: Over Expression, Western Blot, Enzyme-linked Immunosorbent Assay
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Article Title: Levo-tetrahydropalmatine ameliorates neuropathic pain by inhibiting the activation of the Clec7a-MAPK/NF-κB-NLRP3 inflammasome axis.
doi: 10.1016/j.phymed.2023.155075
Figure Lengend Snippet: Fig. 6. L-THP effectively inhibits the upregulation of Clec7a in spinal microglia. Representative images and quantitative analysis of co-localization of Clec7a with Iba-1 (A), GFAP (B) or NeuN (C) in the spinal cord. The tissues were collected from each group of rats on postoperative day 10. White arrows point to Clec7a- positive cells. Scale bars are indicated. Data are presented as mean ± SEM. One-way ANOVA was used to analyze data among multiple groups, followed by Tukey’s post hoc test for equal variances or Dunnett’s T3 post hoc test for unequal variances. *p<0.05, ***p<0.001 compared with the Sham group; ###p < 0.001 compared with the CCI group.
Article Snippet: First, the
Techniques:
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Article Title: Levo-tetrahydropalmatine ameliorates neuropathic pain by inhibiting the activation of the Clec7a-MAPK/NF-κB-NLRP3 inflammasome axis.
doi: 10.1016/j.phymed.2023.155075
Figure Lengend Snippet: Fig. 8. L-THP was directly combined with the Clec7a protein. (A) The schematic diagram of the molecular docking of L-THP with Clec7a, shown as the 3D diagram. The ribbon and stick structure displays the predicted bonds between L-THP and Clec7a. (B) The interaction between L-THP and Clec7a was determined by SPR assay. The equilibrium dissociation constant was evaluated using BIA evaluation software.
Article Snippet: First, the
Techniques: SPR Assay, Software
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Article Title: Levo-tetrahydropalmatine ameliorates neuropathic pain by inhibiting the activation of the Clec7a-MAPK/NF-κB-NLRP3 inflammasome axis.
doi: 10.1016/j.phymed.2023.155075
Figure Lengend Snippet: Fig. 9. The graphical abstract illus trates the proposed mechanism un derlying the effect of L-THP in CCI rats. Several pathways, including Clec7a-MAPK/NF-κB-NLRP3 axis, were activated and promoted the release of proinflammatory cytokines that further promoted neuroinflammation and neuropathic pain. L-THP attenuated CCI- induced neuropathic pain through inhibiting the Clec7a-MAPK/NF-κB- NLRP3 signaling pathway, inhibiting the excessive release of proin flammatory cytokines, and decreasing neuroinflammation in the spinal cord.
Article Snippet: First, the
Techniques: